Senseonics, Welldoc partner to develop mobile app for Eversense 365

GERMANTOWN & COLUMBIA, Md. – Senseonics and Welldoc have announced a strategic partnership to develop a new custom mobile application for the Eversense 365. The next-generation app will maintain all existing features that patients currently benefit from, alongside new features to enhance user experience and facilitate better integration with popular digital health tools. As part of this, the new and improved Eversense 365 app will facilitate seamless integration with Apple Health and Google Health Connect, enabling users to compile all their most valuable health and fitness data into one place. Where available, the app will also continue to support the transformative combination of Eversense 365 with the twiist Automated Insulin Delivery (AID) System, which launched in the U.S. earlier this year. “At Senseonics we’re committed to making the CGM experience as convenient and effective as possible, with excellence at the heart of everything we do,” said Tim Goodnow, CEO, Senseonics. “This makes Welldoc a natural partner for developing our next-generation app and we look forward to leveraging their platform and expertise in AI-powered digital health. Users can also expect a revamped app interface with improved visual components and workflows for all features and functionalities of the current app. In particular, this project will focus on enhancing the user interface and experience of sensor and transmitter integration, including pairing and activation, communication status, synchronization, data displays and alerts. These improvements will ensure that usability and functionality of the app better reflect the outstanding technology of the Eversense 365 CGM system. The new app is expected to launch in the U.S. during the second half of 2026, with availability in European markets early next year.

Related reading:

Senseonics launches Eversense 365 in Sweden, other countries to follow

Senseonics to enter EU markets with Eversense 365 CGM system